Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9396)
All Articles published online
|
Publishing Process of This Article
|
Dec 15, 2013 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Krispel C, Rodrigues M, Xin X, Sodhi A. Ranibizumab in diabetic macular edema. World J Diabetes 2013; 4(6): 310-318 [PMID: 24379922 DOI: 10.4239/wjd.v4.i6.310] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v4/i6/310.htm |
| Number | Citing Articles |
| 1 |
Kaushik Sadhukhan, Tamal Roy, Subhrajyoti Naskar, Dhritashree Mandal. EFFECT OF SINGLE DOSE OF INTRAVITREAL RANIBIZUMAB INJECTION FOLLOWED BY TRABECULECTOMY WITH MITOMYCIN-C IN CASES OF NEOVASCULAR GLAUCOMA WITH HAZY MEDIA OBSCURING PRP IN A PERIPHERAL MEDICAL COLLEGE IN WEST BENGAL. Journal of Evolution of Medical and Dental Sciences 2019; 8(28): 2255 doi: 10.14260/jemds/2019/494
|
| 2 |
Ebru Nevin Cetin, Önder Demirtaş, Nihal Cesur Özbakış, Gökhan Pekel. Quantitative assessment of macular contraction and vitreoretinal interface alterations in diabetic macular edema treated with intravitreal anti-VEGF injections. Graefe's Archive for Clinical and Experimental Ophthalmology 2018; 256(10): 1801 doi: 10.1007/s00417-018-4042-5
|
| 3 |
Jing Zhang, Deepti Sharma, Aumreetam Dinabandhu, Jaron Sanchez, Brooks Applewhite, Kathleen Jee, Monika Deshpande, Miguel Flores-Bellver, Ming-Wen Hu, Chuanyu Guo, Shaima Salman, Yousang Hwang, Nicole M. Anders, Michelle A. Rudek, Jiang Qian, M. Valeria Canto-Soler, Gregg L. Semenza, Silvia Montaner, Akrit Sodhi. Targeting hypoxia-inducible factors with 32-134D safely and effectively treats diabetic eye disease in mice. Journal of Clinical Investigation 2023; 133(13) doi: 10.1172/JCI163290
|
| 4 |
Stijn Moens, Jermaine Goveia, Peter C. Stapor, Anna Rita Cantelmo, Peter Carmeliet. The multifaceted activity of VEGF in angiogenesis – Implications for therapy responses. Cytokine & Growth Factor Reviews 2014; 25(4): 473 doi: 10.1016/j.cytogfr.2014.07.009
|
| 5 |
Jie Li, Bifei Lan, Xiaoli Li, Shumao Sun, Ping Lu, Lingyun Cheng. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous. Journal of Controlled Release 2016; 243: 78 doi: 10.1016/j.jconrel.2016.10.001
|
| 6 |
Akrit Sodhi, Tao Ma, Deepak Menon, Monika Deshpande, Kathleen Jee, Aumreetam Dinabandhu, Jordan Vancel, Daoyuan Lu, Silvia Montaner. Angiopoietin-like 4 binds neuropilins and cooperates with VEGF to induce diabetic macular edema. Journal of Clinical Investigation 2019; 129(11): 4593 doi: 10.1172/JCI120879
|
| 7 |
Douglas A. MacDonald, Joel Martin, Kathir K. Muthusamy, Jiann-Kae Luo, Erica Pyles, Ashique Rafique, Tammy Huang, Terra Potocky, Yang Liu, Jingtai Cao, Françoise Bono, Nathalie Delesque, Pierre Savi, John Francis, Ali Amirkhosravi, Todd Meyer, Carmelo Romano, Meredith Glinka, George D. Yancopoulos, Neil Stahl, Stanley J. Wiegand, Nicholas Papadopoulos. Aflibercept exhibits VEGF binding stoichiometry distinct from bevacizumab and does not support formation of immune-like complexes. Angiogenesis 2016; 19(3): 389 doi: 10.1007/s10456-016-9515-8
|
| 8 |
Minwen Zhou, Jiawei Wang, Wei Wang, Wenbin Huang, Xiaoyan Ding, Xiulan Zhang, N.S. Duesbery. Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection. PLOS ONE 2016; 11(1): e0146993 doi: 10.1371/journal.pone.0146993
|
| 9 |
Nakhleh E Abu-Yaghi, Alaa M Abed, Dana F Khlaifat, Mohammed B Nawaiseh, Laith O Emoush, Heba Z AlHajjaj, Ala M Abojaradeh, Mariana N Hattar, Sura K. Abusaleem, Hashem M Sabbagh, Yazan A Abu Gharbieh, Sura A Quaqazeh. <p>Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients</p>. Clinical Ophthalmology 2020; : 921 doi: 10.2147/OPTH.S248661
|
| 10 |
Haiyan Chen, Xuehui Shi, Wang Zhang, Qianqian Han. Aflibercept versus ranibizumab for diabetic macular edema: A meta-analysis. European Journal of Ophthalmology 2024; 34(3): 615 doi: 10.1177/11206721231178658
|
| 11 |
Chuanyu Guo, Monika Deshpande, Yueqi Niu, Isha Kachwala, Miguel Flores-Bellver, Haley Megarity, Taylor Nuse, Savalan Babapoor-Farrokhran, Michael Ramada, Jaron Sanchez, Neelay Inamdar, Thomas V. Johnson, Maria Valeria Canto-Soler, Silvia Montaner, Akrit Sodhi. HIF-1α accumulation in response to transient hypoglycemia may worsen diabetic eye disease. Cell Reports 2023; 42(1): 111976 doi: 10.1016/j.celrep.2022.111976
|
| 12 |
Savalan Babapoor-Farrokhran, Kathleen Jee, Brooks Puchner, Syed Junaid Hassan, Xiaoban Xin, Murilo Rodrigues, Fabiana Kashiwabuchi, Tao Ma, Ke Hu, Monika Deshpande, Yassine Daoud, Sharon Solomon, Adam Wenick, Gerard A. Lutty, Gregg L. Semenza, Silvia Montaner, Akrit Sodhi. Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy. Proceedings of the National Academy of Sciences 2015; 112(23) doi: 10.1073/pnas.1423765112
|
| 13 |
Yannis M. Paulus, Akrit Sodhi. Pharmacologic Therapy of Ocular Disease. Handbook of Experimental Pharmacology 2016; 242: 271 doi: 10.1007/164_2016_78
|
| 14 |
An Shao, Lulu Jin, Yanni Ge, Ziqiang Ye, Mingyu Xu, Yifan Zhou, Yingyu Li, Linyan Wang, Pinglong Xu, Kai Jin, Zhengwei Mao, Juan Ye. C176-loaded and phosphatidylserine-modified nanoparticles treat retinal neovascularization by promoting M2 macrophage polarization. Bioactive Materials 2024; 39: 392 doi: 10.1016/j.bioactmat.2024.05.038
|
| 15 |
Jean-Francois Korobelnik, Jos Kleijnen, Shona H Lang, Richard Birnie, Regina M Leadley, Kate Misso, Gill Worthy, Dominic Muston, Diana V Do. Systematic review and mixed treatment comparison of intravitreal aflibercept with other therapies for diabetic macular edema (DME). BMC Ophthalmology 2015; 15(1) doi: 10.1186/s12886-015-0035-x
|
| 16 |
Jing Zhang, Yaowu Qin, Mireya Martinez, Miguel Flores-Bellver, Murilo Rodrigues, Aumreetam Dinabandhu, Xuan Cao, Monika Deshpande, Yu Qin, Silvia Aparicio-Domingo, Yuan Rui, Stephany Y. Tzeng, Shaima Salman, Jin Yuan, Adrienne W. Scott, Jordan J. Green, M. Valeria Canto-Soler, Gregg L. Semenza, Silvia Montaner, Akrit Sodhi. HIF-1α and HIF-2α redundantly promote retinal neovascularization in patients with ischemic retinal disease. Journal of Clinical Investigation 2021; 131(12) doi: 10.1172/JCI139202
|
| 17 |
Abdel-RahmanE Sarhan, SamehS Mandour, AhmedZ Zayed. Evaluation of intravitreal injection of ranibizumab in diabetic macular edema. Menoufia Medical Journal 2019; 32(4): 1447 doi: 10.4103/mmj.mmj_410_18
|